Skip to main content
OpenTrials

Clinical trial condition

RAS-mutant Colorectal Cancer

Explore clinical trials studying RAS-mutant Colorectal Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

RAS-mutant Colorectal Cancer trial results

Completed

Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation

NCT03271047

Conditions
MSS, Neoplasms, RAS-mutant Colorectal Cancer
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • UCLA Hematology/Oncology - Santa Monica Santa Monica, California, United States
  • Christiana Care Health Services, Helen F. Graham Cancer Center Pharmacy, Suite 3200 Newark, Delaware, United States
  • Christiana Care Health Services, Helen F. Graham Cancer Center Newark, Delaware, United States
View all 50 locations
View Trial Details

Related conditions